Apatinib in Combination With S-1 as First-Line Treatment in Patients With Advanced Gastric Cancer

NCT02525237 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Apatinib
DRUG: S-1

Sponsor

Qingdao Municipal Hospital

Collaborators

[object Object]